[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Gynuity Health Projects\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":69},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,41],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":26,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":40},"100536840","evaluation-of-telemedicine-medical-abortion-service-in-ecuador-100536840",false,"NCT06270056","Evaluation of Telemedicine Medical Abortion Service in Ecuador","Evaluation of Telemedicine Services to Address Urgent Issues Related to Sexual and Reproductive Rights in Ecuador","Inclusion Criteria:\n\n* Woman is seeking abortion care and wants to use telemedicine service for her medication abortion procedure.\n* Woman has access to an internet connection or a device that allows remote consultation.\n* Woman is 15 years of age or older.\n* Woman can provide an address to which abortion medications will be mailed.\n* Woman reports having no contraindications to a medical abortion.\n* The study provider does not suspect ectopic pregnancy or a nonviable pregnancy.\n* The gestational age allows sufficient time for the woman to take the misoprostol no later than 84 days of gestation.\n* A feasible plan is made that the woman agrees to confirm complete abortion and to seek care to manage incomplete abortion complications.\n* The woman understands the study procedures and is likely to comply with study instructions and has granted informed consent to participate in the study.\n\nExclusion Criteria:\n\n* Medically ineligible for procedure.\n* Provider determines that a medical abortion using the telemedicine approach is not appropriate for that person.",true,"FEMALE","15 Years",{"count":20,"type":21},100,"ESTIMATED","OBSERVATIONAL","This research seeks to demonstrate that a telemedicine model for the provision of legal abortion services in Ecuador is safe, feasible and acceptable to users requesting a medication abortion and who are less than 12 weeks pregnant.",[25],"Pregnancy",[27],"abortion","RECRUITING","2024-10-11",{"date":31,"type":32},"2024-10-15","ACTUAL",{"date":34,"type":32},"2024-07-24",{"date":36,"type":21},"2025-09",{"name":38,"class":39},"Gynuity Health Projects","OTHER",3,{"id":42,"slug":43,"hasResults":11,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":4,"eligibilityCriteria":47,"healthyVolunteers":16,"sex":17,"minAge":48,"maxAge":49,"enrollmentInfo":50,"targetDuration":4,"studyType":52,"phases":53,"briefSummary":56,"conditions":57,"keywords":4,"overallStatus":60,"whyStopped":4,"lastUpdateSubmitDate":61,"lastUpdatePostDateStruct":62,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":4},"100553961","phase-2-assessing-the-efficacy-and-acceptability-of-two-missed-period-pills-regimens-100553961","NCT06492889","Assessing the Efficacy and Acceptability of Two Missed Period Pills Regimens","Randomized Trial Comparing Progestin With Mifepristone Versus Mifepristone Alone for Use as Missed Period Pills","Inclusion Criteria:\n\n* Age 15-49 years\n* General good health\n* Does not want to be pregnant\n* History of regular monthly menstrual cycles (+\u002F- 3 days)\n* Missed menses of 2 to 8 days\n* Sexual activity in the past month\n* Willing and able to sign consent forms\n* Willing to return for a follow-up visit\n* Willing to provide urine sample at enrollment and follow-up\n\nExclusion Criteria:\n\n* Known allergies or contraindications to either study drug\n* Symptoms or risk factors for ectopic pregnancy\n* Current use of an IUD, contraceptive implant or injectable","18 Years","49 Years",{"count":51,"type":21},286,"INTERVENTIONAL",[54,55],"PHASE2","PHASE3","The goal of this trial is to examine the efficacy and acceptability of two medication regimens at inducing a return of menses when used 2-8 days after a missed period. The first regimen consists of one dose of 1.5 mg levonorgestrel followed one to two days later by one dose of 200 mg mifepristone. The second regimen will consist of one dose of a placebo pill, followed one to two days later by one dose of 200 mg mifepristone.\n\nThe investigators will assess and compare the efficacy of both regimens (proportion of women in each group not pregnant at follow-up who were determined to be pregnant at enrollment), and the effectiveness of both regimens (proportion of all participants not pregnant at follow-up among all participants enrolled)",[58,59],"Pregnancy Early","Pregnancy Related","NOT_YET_RECRUITING","2024-07-17",{"date":63,"type":32},"2024-07-18",{"date":65,"type":21},"2024-07-22",{"date":67,"type":21},"2025-06-30",{"name":38,"class":39},""]